301 related articles for article (PubMed ID: 16516918)
1. Bradykinin prevents reperfusion injury by targeting mitochondrial permeability transition pore through glycogen synthase kinase 3beta.
Park SS; Zhao H; Mueller RA; Xu Z
J Mol Cell Cardiol; 2006 May; 40(5):708-16. PubMed ID: 16516918
[TBL] [Abstract][Full Text] [Related]
2. N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogen synthase kinase 3 beta.
Park SS; Zhao H; Jang Y; Mueller RA; Xu Z
J Pharmacol Exp Ther; 2006 Jul; 318(1):124-31. PubMed ID: 16611852
[TBL] [Abstract][Full Text] [Related]
3. Sevoflurane confers additive cardioprotection to ethanol preconditioning associated with enhanced phosphorylation of glycogen synthase kinase-3β and inhibition of mitochondrial permeability transition pore opening.
Onishi A; Miyamae M; Inoue H; Kaneda K; Okusa C; Inamura Y; Shiomi M; Koshinuma S; Momota Y; Figueredo VM
J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):916-24. PubMed ID: 23266287
[TBL] [Abstract][Full Text] [Related]
4. NECA at reperfusion limits infarction and inhibits formation of the mitochondrial permeability transition pore by activating p70S6 kinase.
Förster K; Paul I; Solenkova N; Staudt A; Cohen MV; Downey JM; Felix SB; Krieg T
Basic Res Cardiol; 2006 Jul; 101(4):319-26. PubMed ID: 16604438
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effect of morphine and a blocker of glycogen synthase kinase 3 beta, SB216763 [3-(2,4-dichlorophenyl)-4(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione], via inhibition of the mitochondrial permeability transition pore.
Obame FN; Plin-Mercier C; Assaly R; Zini R; Dubois-Randé JL; Berdeaux A; Morin D
J Pharmacol Exp Ther; 2008 Jul; 326(1):252-8. PubMed ID: 18434587
[TBL] [Abstract][Full Text] [Related]
6. Isoflurane postconditioning prevents opening of the mitochondrial permeability transition pore through inhibition of glycogen synthase kinase 3beta.
Feng J; Lucchinetti E; Ahuja P; Pasch T; Perriard JC; Zaugg M
Anesthesiology; 2005 Nov; 103(5):987-95. PubMed ID: 16249673
[TBL] [Abstract][Full Text] [Related]
7. Ethanol prevents oxidant-induced mitochondrial permeability transition pore opening in cardiac cells.
Zhou K; Zhang L; Xi J; Tian W; Xu Z
Alcohol Alcohol; 2009; 44(1):20-4. PubMed ID: 19033378
[TBL] [Abstract][Full Text] [Related]
8. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3beta.
Chanoit G; Lee S; Xi J; Zhu M; McIntosh RA; Mueller RA; Norfleet EA; Xu Z
Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1227-H1233. PubMed ID: 18660440
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide prevents the mitochondrial permeability transition pore opening by inactivating glycogen synthase kinase 3β via PKG and PI3K in cardiac H9c2 cells.
Hong L; Xi J; Zhang Y; Tian W; Xu J; Cui X; Xu Z
Eur J Pharmacol; 2012 Nov; 695(1-3):13-9. PubMed ID: 22975711
[TBL] [Abstract][Full Text] [Related]
10. Ischemic post-conditioning reduces infarct size of the in vivo rat heart: role of PI3-K, mTOR, GSK-3beta, and apoptosis.
Wagner C; Tillack D; Simonis G; Strasser RH; Weinbrenner C
Mol Cell Biochem; 2010 Jun; 339(1-2):135-47. PubMed ID: 20054613
[TBL] [Abstract][Full Text] [Related]
11. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
12. Role of 70-kDa ribosomal protein S6 kinase, nitric oxide synthase, glycogen synthase kinase-3 beta, and mitochondrial permeability transition pore in desflurane-induced postconditioning in isolated human right atria.
Lemoine S; Zhu L; Beauchef G; Lepage O; Babatasi G; Ivascau C; Massetti M; Galera P; Gérard JL; Hanouz JL
Anesthesiology; 2010 Jun; 112(6):1355-63. PubMed ID: 20460998
[TBL] [Abstract][Full Text] [Related]
13. Anti-hypertrophic effect of NHE-1 inhibition involves GSK-3beta-dependent attenuation of mitochondrial dysfunction.
Javadov S; Rajapurohitam V; Kilić A; Zeidan A; Choi A; Karmazyn M
J Mol Cell Cardiol; 2009 Jun; 46(6):998-1007. PubMed ID: 19318234
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection.
Nishihara M; Miura T; Miki T; Tanno M; Yano T; Naitoh K; Ohori K; Hotta H; Terashima Y; Shimamoto K
J Mol Cell Cardiol; 2007 Nov; 43(5):564-70. PubMed ID: 17931653
[TBL] [Abstract][Full Text] [Related]
15. Rosuvastatin protects isolated hearts against ischemia-reperfusion injury: role of Akt-GSK-3β, metabolic environment, and mitochondrial permeability transition pore.
Vélez DE; Mestre-Cordero VE; Hermann R; Perego J; Harriet S; Fernandez-Pazos MLM; Mourglia J; Marina-Prendes MG
J Physiol Biochem; 2020 Feb; 76(1):85-98. PubMed ID: 31916218
[TBL] [Abstract][Full Text] [Related]
16. Role of glycogen synthase kinase 3β in protective effect of propofol against hepatic ischemia-reperfusion injury.
Zhao G; Ma H; Shen X; Xu GF; Zhu YL; Chen B; Tie R; Qu P; Lv Y; Zhang H; Yu J
J Surg Res; 2013 Nov; 185(1):388-98. PubMed ID: 23743186
[TBL] [Abstract][Full Text] [Related]
17. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
[TBL] [Abstract][Full Text] [Related]
18. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.
Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L
Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715
[TBL] [Abstract][Full Text] [Related]
19. Hypercholesterolemia abrogates the cardioprotection of ischemic postconditioning in isolated rat heart: roles of glycogen synthase kinase-3β and the mitochondrial permeability transition pore.
Wu N; Zhang X; Guan Y; Shu W; Jia P; Jia D
Cell Biochem Biophys; 2014 May; 69(1):123-30. PubMed ID: 24213808
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phosphodiesterases leads to prevention of the mitochondrial permeability transition pore opening and reperfusion injury in cardiac H9c2 cells.
Chanoit G; Zhou J; Lee S; McIntosh R; Shen X; Zvara DA; Xu Z
Cardiovasc Drugs Ther; 2011 Aug; 25(4):299-306. PubMed ID: 21643720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
